Health and Social Care Committee Inquiry
The Health and Social Care Select Committee at Westminster held an evidence hearing on 7 March as part of an inquiry into the availability of Orkambi and other precision medicines for cystic fibrosis.
Access to Orkambi was once again the subject of debate in the House of Commons chamber on Monday 4 February. Bill Wiggin MP tabled the adjournment debate ‘Crown Use License for Orkambi’. Watch the afternoon session in the Commons via Parliament TV.
On Monday 19 November 2018, which marked three years since the drug Orkambi was licensed for use in the UK by the European Medicines Agency (EMA), the Trust held a Parliamentary event in the Houses of Parliament to discuss access to medicines for people with cystic fibrosis, sponsored by Ian Austin MP.
Find out whether your MP attended here.
We have sent a cross-party letter to Jeremy Hunt, Secretary of State for Health and Department of Health Permanent Secretary, Richard Pengelly, calling for a timely resolution to the ongoing negotiations between Vertex and Health and Social Care Northern Ireland. These letters have been signed by 66 MLAs from a number of different parties.
Read the letters:
We have received a response to our letters from Richard Pengelly, which you can read here:
Vertex Pharmaceuticals has agreed to make submissions for its cystic fibrosis medicines, Orkambi and Symkevi, to the Scottish Medicines Consortium (SMC). The First Minister, Nicola Sturgeon, has responded to an oral question from Jackie Baillie MSP on 20 December confirming that a price agreement has been reached and agreed between Vertex and the Scottish Government pending a submission of both medicines. In the meantime, patients in Scotland can access the treatments in the interim via PACs Tier 2 patient access scheme. For further information on this scheme please speak with your CF team.
A cross-party meeting was held at the Scottish Parliament a on Wednesday 21 November to discuss access to medicines for cystic fibrosis in Scotland. The meeting was organised and chaired by Jackie Baillie MSP.
For more information about the meeting, have a look at the blog by Nick Medhurst, Head of Policy and Public Affairs at the Trust.
On 29 January 2019, the Welsh Assembly petitions committee discussed the petition to ‘Ensure access to the cystic fibrosis medicine Orkambi as a matter of urgency’ and the committee agreed to write again to the Minister for Health and Social Services, Vaughan Gething, regarding a means of interim access for the drug in Wales. You can watch a recording of the session and view the submissions.
Find out if your Assembly Member has recently tabled a written question on this matter here.
Find your AMs
Write to the Health Minister
Matt Hancock, Secretary of State for Health and Social Care, met with Vertex, NHS England and NICE on Monday 9 March. We need to send a powerful message to Matt Hancock’s Welsh counterpart, Minister for Health and Social Services, Vaughan Gething AM to urge him to engage personally and ensure access to life-saving drugs now in Wales.
Therefore, we are asking you to send a letter to the Minister.
Working alongside parent, Kim Roberts, we’d like you to explain in a letter:
- How cystic fibrosis affects you and your family,
- what this agonising wait has meant for your health and,
- what why you need access to life-saving drugs now
Send your letters to the Trust for the attention of C/O G Paget, Cystic Fibrosis Trust, One Aldgate, London EC3N 1RE and we’ll hand them in on your behalf.
For the latest news on our Stopping the Clock campaign and other updates in the CF community, sign up to receive our e-newsletter.